嘉興燃氣(09908.HK):部分超額配股權獲行使涉及450.45萬股 穩定價格期結束
格隆匯8月7日丨嘉興燃氣(09908.HK)發佈公告,交銀國際證券於2020年8月7日行使招股章程所述的部分超額配股權以補足國際配售中的超額分配,涉及合共450.45萬股額外H股,相當於超額配股權獲任何行使前根據全球發售初步提呈的發售股份總數約13.51%。公司將按全球發售下每股H股的發售價每股H股10港元發行及配發超額分配H股。
根據香港法例第571W章證券及期貨規則第9(2)條,有關全球發售的穩定價格期間於2020年8月7日結束,即遞交香港公開發售申請截止當日後第30日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.